Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$27,000.00
Building and validating a pipeline using reverse transcriptome mapping for cardiovascular disease
EF 2024-25
Résumé
In Canada, cardiovascular disease is the leading cause of death. However, the progress of developing new therapeutics for cardiovascular disease has slowed down in the past three decades. Finding new therapeutic targets and taking a new drug from bench-to-bedside can take more than 10 years and cost over $100 million USD to run clinical trials. Re-developing a clinically approved drug to treat cardiovascular disease can reduce the time and cost needed by half. There have been successful cases of repurposing treatment for gout and diabetic patients to treat patients with cardiovascular disease. Selecting promising drugs for repurposing is sometimes opportunistic based on observation and coincidence. For example, colchicine was selected because gout patients taking this drug have reduced future risk of developing cardiovascular disease. We lack a systematic approach to efficiently select promising candidates based on existing drug and disease databases. My project aims to develop a computational approach to perform a systematic search for these candidates. I plan to build a new statistical model and validate our approach using two successfully repurposed drugs, including colchicine. My long-term goal is to implement and generalize this approach into a user-friendly online app for cardiovascular researchers to discover potential drugs to repurpose, in disease contexts beyond the scope of what colchicine can cure. In this way, researchers from diverse fields can use reputable public databases to identify promising treatments without having advanced computational coding skills or datasets generated in-house.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529773
Name
Leung Samuel
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Building and validating a pipeline using reverse transcriptome mapping for cardiovascular disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular Disease; Drug Repurposing; Heart Failure; Pipeline Development
Abstract
In Canada, cardiovascular disease is the leading cause of death. However, the progress of developing new therapeutics for cardiovascular disease has slowed down in the past three decades. Finding new therapeutic targets and taking a new drug from bench-to-bedside can take more than 10 years and cost over $100 million USD to run clinical trials. Re-developing a clinically approved drug to treat cardiovascular disease can reduce the time and cost needed by half. There have been successful cases of repurposing treatment for gout and diabetic patients to treat patients with cardiovascular disease. Selecting promising drugs for repurposing is sometimes opportunistic based on observation and coincidence. For example, colchicine was selected because gout patients taking this drug have reduced future risk of developing cardiovascular disease. We lack a systematic approach to efficiently select promising candidates based on existing drug and disease databases. My project aims to develop a computational approach to perform a systematic search for these candidates. I plan to build a new statistical model and validate our approach using two successfully repurposed drugs, including colchicine. My long-term goal is to implement and generalize this approach into a user-friendly online app for cardiovascular researchers to discover potential drugs to repurpose, in disease contexts beyond the scope of what colchicine can cure. In this way, researchers from diverse fields can use reputable public databases to identify promising treatments without having advanced computational coding skills or datasets generated in-house.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Leung, Samuel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~